Official recall notice

FDA DrugClass IINotable

FDA Recall: Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover

Recall date
2026-04-15
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

CGMP Deviations: use of an unapproved raw material

Recommended action

What to do

124,054 Cartons

Product description

CGMP Deviations: use of an unapproved raw material

Verify with the official notice →
Share:

Related Recalls

2026-09-09 · FDA_DRUG
FDA Recall: traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva
Teva Pharmaceuticals USA, Inc
2026-05-13 · FDA_DRUG
FDA Recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose k
Teva Pharmaceuticals USA, Inc
2026-04-29 · FDA_DRUG
FDA Recall: Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with
Teva Pharmaceuticals USA, Inc
2026-04-15 · FDA_DRUG
FDA Recall: Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover
Teva Pharmaceuticals USA, Inc